| 1 |
中华医学会消化病学分会炎症性肠病协作组．中国炎症性肠病诊断治疗规范的共识意见[J]．中华内科杂志，2008，47(1):73-79.
|
| 2 |
Flynn S, Eisenstein S．Inflammatory Bowel Disease Presentation and Diagnosis[J]．Surg Clin North Am，2019，99(6):1051-1062.
|
| 3 |
Echarri Piudo A．Inflammatory bowel disease - Newer models of care[J]．Rev Esp Enferm Dig，2019，111(8):577-578.
|
| 4 |
Hanić M, Trbojević-AkmaičIć, Lauc G．Inflammatory bowel disease-glycomics perspective[J]．Biochim Biophys Acta Gen Subj，2019，1863(10):1595-1601.
|
| 5 |
Pisani LF, Moriggi M, Gelfi C，et al.Proteomic insights on the metabolism in inflammatory bowel disease[J]．World J Gastroenterol，2020，26(7):696-705.
|
| 6 |
Johne B, Fagerhol M K, Lybrg T，et al.Functional and cEnical aspects of the myelomonocyte protein calprotectin[J]．J Clin Path-Mol Path，1997，50(3):113-123.
|
| 7 |
Gebhardt C, Nemeth J, Angel P，et al.S100A8 and S100A9 in inflammation and cancer[J]．Biochemical Pharmacology，2006，72(11):1622-1631.
|
| 8 |
Roseth AG, Schmidt PN, Fagerhol MK.Correlation between faecal excretion of indium-111 -labelled granulocytes and calprotectin，a granulocyte maricer protein，in patients with inflammatory bowel disease[J]．Scand J Gagtroentero，1999，34(1):50-54.
|
| 9 |
Sander J, Fagerlol MK, Bakkon JS，et al.Plasma levels of the leukocyte LI protein in febrile conditions：relation to aetilolgy t number of leucocytes in blood，blood sedimentation reaction and C-reaction protein[J]．Scand J Clin Lav Invest，1984，44(4):357-362.
|
| 10 |
Ayling RM, Kok K．Fecal Calprotectin[J]．Adv Clin Chem，2018，87:161-190.
|
| 11 |
Ricciuto A, Griffiths AM.Clinical value of fecal calprotectin[J]．Crit Rev Clin Lab Sci，2019，56(5):307-320.
|
| 12 |
Vernia F, Di Ruscio M, Stefanelli G，et al.Is fecal calprotectin an accurate marker in the management of Crohn′s disease？[J]．J Gastroenterol Hepatol，2020，35(3):390-400.
|
| 13 |
20 Caviglia GP, Ribaldone DG, Rosso C，et al.Fecal calprotectin：beyond intestinal organic diseases[J]．Panminerva Med，2018，60(1):29-34.
|
| 14 |
Mumolo MG, Bertani L, Ceccarelli L，et al.From bench to bedside：Fecal calprotectin in inflammatory bowel diseases clinical setting[J]．World J Gastroenterol，2018，24(33):3681-3694.
|
| 15 |
Mosli MH, Zou G, Garg SK，et al.C-Reactive Protein，Fecal Calprotectin，and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients：A Systematic Review and Meta-Analysis[J]．Am J Gastroenterol，2015，110(6):802-819;quiz 820.
|
| 16 |
Sharbatdaran M, Holaku A, Kashifard M，et al.Fecal calprotectin Level in patients with IBD and noninflammatory disease of colon：a study in Babol，Northern，Iran[J]．Caspian J Intern Med，2018，9(1):60-64.
|
| 17 |
Sands BE.Biomarkers of Inflammation in Inflammatory Bowel Disease[J]．Gastroenterology，2015，149(5):1275-1285.
|
| 18 |
Roseth A G, Fageriiol M K, Aadland E．Assessment of the neutrophil dominating protein calprotectin in feces，a methodogic study[J]．Scand J Gastroenterol，1992，27(9):793-798.
|
| 19 |
Inch R D, Pont E D, Leo V D，et al.Calprotectin and lactoferrin in the assessmen of intestinal inflammation and organic disease[J]．Int J Colorectal Dis，2007，22(4)429-437.
|
| 20 |
Schoepfer A M, Trummler M, Seeholzer P，et al.Accuracy of four fecal assays in the diagnosis of colitis[J]．Dis Colon Rectum，2007，50(10):1697-1706.
|
| 21 |
Younes C．Fecal calprotectin and RT-PCR from both nasopharyngeal swab and stool samples prior to treatment decision in IBD patients during CoVID-19 outbreak[J]．Dig Liver Dis，2020，52(11):1230.
|
| 22 |
Menees SB, Powell C, Kurlander J，et al.A meta-analysis of the utility of C-reactive protein，erythrocyte sedimentation rate，fecal calprotectin，and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS[J]．Am J Gastroenterol，2015，110(3):444-454.
|
| 23 |
Klingberg E, Magnusson MK, Strid H，et al.A distinct gut microbiota composition in patients with ankylosing spondylitis is associated with increased levels of fecal calprotectin[J]．Arthritis Res Ther，2019，21(1):248.
|
| 24 |
Bertani L, Mumolo MG, Tapete G，et al.Fecal calprotectin：current and future perspectives for inflammatory bowel disease treatment[J]．Eur J Gastroenterol Hepatol，2020，32(9):1091-1098.
|